Israeli startup claims to succeed where Theranos failed
fromthegrapevine.com
fromthegrapevine.com
Maybe the one in the article is cheaper or something?
The real cleverness of that system is in the sampling tube, which contains all the chemistry, has the needle used for taking the sample, and can be centrifuged. The machine is just a centrifuge plus light sources and cameras to look at the tube. The tube is about $6 each.[2]
Apparently this isn't new; the concept dates from 1977. Nicely executed here in a compact one-button desktop unit.
[1] https://druckerdiagnostics.com/products/dry-hematology-analy...
[2] https://www.devineexpress.com/products/429625-qbc-diagnostic...
A non-Theranos example might make it clear why I'm not nuts about the "if they'd succeeded, we'd be singing a different tune" argument:
If alchemists had been successful in turning lead into gold, nobody would be calling them frauds now.
2) Generally, the full blood draw serves as an averaging filter. We know that concentrations of chemicals in the body vary significantly with time, position, etc. Pulling more blood over several seconds serves to average some of this out.
It sounds like they have a very restricted scope compared to Theranos. Testing for one or two things in a drop of finger blood isn't anything new, as many diabetics can attest to. As I understand it the "magic" theranos was originally trying to accomplish [before they decided to scam people instead] was a wide variety of blood tests from a single drop of blood.
I'm skeptical of that, since my impression is that the many of the capillaries in one's finger are so tiny that only one blood cell can fit through at a time. That seems like something that could fuck up the results, but I'm no doctor or biologist and it sounds like regulators might actually be paying attention this time around.
Deciding 'we'll scam people, but only for a short while' is still deciding to scam people.
> Unlike Theranos, Sight Diagnostics is starting small and working its way up. Holmes claimed her device could do hundreds of tests across the four main classes of blood tests: hematology, immunoassays, general chemistry and DNA amplification. Sight is only focusing on a subset of hematology for now.
So, in truth, they're not anywhere close to trying to do what Theranos promised. The book Bad Blood goes into the technical details that made Theranos's mission fantastical if not farcical. The scope of it is very different.
This was one of the most telling passages for me in Bad Blood:
Tim [Timothy Hamill, Vice Chair of UCSF's Dept of Laboratory Medicine] confirmed to me that both practices were highly questionable. He also explained the pitfalls of using blood pricked from a finger. Unlike venous blood drawn from the arm, capillary blood was polluted by fluids from tissues and cells that interfered with tests and made measurements less accurate. "I'd be less surprised if they told us they were time travelers who came back from the twenty-seventh century than if they told us they cracked that nut," he said. (p. 230)
https://www.goodreads.com/book/show/38799469-bad-blood
Consider, too, the source here:
From The Grapevine was created to provide a fresh perspective on Israel. From the land’s natural beauty to Tel Aviv's vibrant technology scene; from the global culinary world's focus on Israeli food and recipes to the innovative Israelis who are changing the world – From The Grapevine covers the bounty of what Israel is about today, in detail, with great writing, rich photographs, and its own editorial voice – engaging, non-political, and non-religious. From The Grapevine tells the stories about Israel you may have missed, but not for much longer, as our engaged social media community begins to share our words. If you find a story that speaks to you, please pass it along, and tell others you heard about it From The Grapevine.
From The Grapevine.com is published by The reThink Israel Initiative, Inc, an American non-profit 501c3 corporation.
https://www.fromthegrapevine.com/about
Looks like a platform for fluff.